NCT00216203 Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00215722 XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00207155 An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00207116 An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma Status COMPLETED Phase PHASE1
NCT00203931 Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00193453 Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00182715 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00169247 Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation Status COMPLETED Phase PHASE2
NCT00165490 Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00165334 Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer Status COMPLETED Phase PHASE2
NCT00162110 A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces Status COMPLETED Phase PHASE2
NCT00154102 Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL) Status COMPLETED Phase PHASE3
NCT00153998 Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) Status COMPLETED Phase PHASE2
NCT00148109 Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Status COMPLETED Phase PHASE2
NCT00142428 Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00134069 Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00130689 Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00125034 Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT00124618 Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2